POLEWACZYK JAMES F 4

Accession 0000874716-24-000065

CIK 0000874716other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 5:00 PM ET

Size

22.7 KB

Accession

0000874716-24-000065

Form 4

Period: 2024-03-06

Corporate Vice President

Transactions

Exercise/Conversion
Common Stock
2024-03-06$544.08/sh+4,640$2,524,531→ 18,815.235 total
Exercise/Conversion
Incentive Stock Option (right-to-buy)
2024-03-06−483→ 0 total
Exercise: $206.94Exp: 2029-02-13→ Common Stock (483 underlying)
Sale
Common Stock
2024-03-06$557.94/sh−4,134$2,306,528→ 14,681.235 total
Sale
Common Stock
2024-03-06$558.88/sh−3,290$1,838,722→ 11,391.235 total
Sale
Common Stock
2024-03-06$559.33/sh−680$380,346→ 10,711.235 total
Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2024-03-06−755→ 0 total
Exercise: $206.94Exp: 2029-02-13→ Common Stock (755 underlying)
Exercise/Conversion
Common Stock
2024-03-06$288.78/sh+2,226$642,824→ 14,175.235 total
Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2024-03-06−2,226→ 0 total
Exercise: $288.78Exp: 2030-02-13→ Common Stock (2,226 underlying)
Exercise/Conversion
Common Stock
2024-03-06$206.94/sh+755$156,240→ 11,466.235 total
Exercise/Conversion
Common Stock
2024-03-06$206.94/sh+483$99,952→ 11,949.235 total
Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2024-03-06−4,640→ 1,363 total
Exercise: $544.08Exp: 2031-02-13→ Common Stock (4,640 underlying)

Footnotes (7)

[F1]Represents the weighted average price of the shares sold ranging from a low of $557.33 to a high of $558.32 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
[F2]Represents the weighted average price of the shares sold ranging from a low of $558.45 to a high of $559.29 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
[F3]Represents the weighted average price of the shares sold ranging from a low of $559.51 to a high of $559.74 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
[F4]Grant of option to buy 5,711 shares of Issuer common stock that vest in five annual installments beginning February 14, 2020.
[F5]Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2024.
[F6]Grant of option to buy 8,906 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021.
[F7]Grant of option to buy 6,003 shares of Issuer common stock that vest in four annual installments beginning February 14, 2022.

Documents

1 file

IDEXX LABORATORIES INC /DE

CIK 0000874716

Entity typeother